Has Cencora (COR) been one of those stocks this year? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.

Three differences exist between the two images. Dive into this picturesque ... The image provided above depicts a summer landscape. There is a river flowing, and a bridge is built over it.

Have you been paying attention to shares of Cencora (COR)? Shares have been on the move with the stock up 8.3% over the past month. The stock hit a new 52-week high of $271.86 in the previous session.

Shares of Cencora Inc. COR rose 1.92% to $279.15 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 3.46% to 5,268.05 and ...

Shares of NYSE COR opened at $284.46 on Friday. The company has a debt-to-equity ratio of 16.40, a quick ratio of 0.54 and a current ratio of 0.92. Cencora has a fifty-two week low of $214.77 and ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Cencora (COR – Research Report) and Johnson & Johnson (JNJ – Research Report). Discover ...

Bank of America Securities analyst Allen Lutz maintained a Hold rating on Cencora (COR – Research Report) today. The company’s shares opened today at $281.79. Discover outperforming stocks and ...

Cencora COR has outperformed the market over the past 10 years by 7.55% on an annualized basis producing an average annual return of 18.31%. Currently, Cencora has a market capitalization of $52. ...

Chesterbrook, PA-based Cencora is one of the world’s largest pharmaceutical services companies, which focuses on providing drug distribution and related services to reduce health care costs and ...